share_log

Iterum Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Fishman Corey N.

SEC ·  Nov 21, 2023 06:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more